TLX 5902931P2Recalls & reported problems
Nuvasive, Inc. · TLX20, 9x11x31mm 20° · Class 2 · Implant
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00887517958419), received between Jan 14, 2025 and Mar 14, 2025 — classified as 2 injuries, 1 malfunction.
The most frequently reported specific device problem is “Migration” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Migration1
Patient problems
- Ambulation or Postural Difficulties1
- Back pain1
- Chest Pain1
- Limb Pain1
- Muscle Weakness/Atrophy1
- No Clinical Signs, Symptoms or Conditions1
- Numbness1
- Pneumonia1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryMar 14, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE EVENT WAS IDENTIFIED DURING A REVIEW OF THE LUMBAR INTERBODY STUDY, THE REPORT IDENTIFIED THAT ON (B)(6) 2024 TRANSFORAMINAL LUMBAR INTERBODY FUSION AT L5-S1 WITH BILATERAL POSTERIOR FIXATION L5-S1. ON (B)(6) 2024 PULMONARY EMBOLISM PRESENTED TO THE ED ON (B)(6)2024 WITH ACUTE ONSET CHEST PAIN THAT RADIATES INTO THE BACK PAIN WAS SO SEVERE PATIENT TOOK AN OXYCODONE PRIOR TO ED ARRIVAL. ON EXAM IN ED, AFEBRILE, TACHYPNEA, SATING 93% RA AND CT SHOWED SMALL ACUTE PE AND RIGHT UPPER LOBE, RIGHT LOWER LOBE SHOWS GROUND-GLASS CHANGES WITH ATELECTASIS CONCERN FOR POSSIBLE PULMONARY INFARCT. PATIENT WAS ADMITTED ON HEPARIN DRIP. ALSO CONCERN FOR COMMUNITY ACQUIRED PNEUMONIA BASED ON CT AND ELEVATED WBC. STABLE ON DISCHARGE ON (B)(6) 2024 ON (B)(6) 2025, PATIENT HAS BEEN EXPERIENCING SIGNIFICANTLY WORSENING LLE PAIN, WORSE SINCE SURGERY. REPORTS A LIMP AND DIFFICULTY AMBULATING WITH HIS LLE, REPORTING THIS IS NEW SINCE SURGERY. ALSO DOES REPORT EPISODES OF HIS LEFT LEG GIVING OUT ON HIM AND LLE WEAKNESS. PATIENT REPORTS SIGNIFICANT PAIN BEHIND LEFT KNEE AND OUTSIDE LEFT KNEE AND LEG TURNING INTO NUMBNESS ON THE OUTER PORTION OF HIS FOOT AND TOES. HE REPORTS HIS TOES ARE CURLED.
Patient problems: Ambulation or Postural Difficulties; Limb Pain; Muscle Weakness/Atrophy; Numbness
MAUDE report 21609912 ↗InjuryMar 11, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE EVENT WAS IDENTIFIED DURING A REVIEW OF THE LUMBAR INTERBODY STUDY, THE REPORT IDENTIFIED THAT ON (B)(6) 2024 TRANSFORAMINAL LUMBAR INTERBODY FUSION AT L5-S1 WITH BILATERAL POSTERIOR FIXATION L5-S1. ON (B)(6) 2024 PULMONARY EMBOLISM PRESENTED TO THE ED ON (B)(6) 2024 WITH ACUTE ONSET CHEST PAIN THAT RADIATES INTO THE BACK PAIN WAS SO SEVERE PATIENT TOOK AN OXYCODONE PRIOR TO ED ARRIVAL. ON EXAM IN ED, AFEBRILE, TACHYPNEA, SATING 93% RA AND CT SHOWED SMALL ACUTE PE AND RIGHT UPPER LOBE, RIGHT LOWER LOBE SHOWS GROUND-GLASS CHANGES WITH ATELECTASIS CONCERN FOR POSSIBLE PULMONARY INFARCT. PATIENT WAS ADMITTED ON HEPARIN DRIP. ALSO CONCERN FOR COMMUNITY ACQUIRED PNEUMONIA BASED ON CT AND ELEVATED WBC. STABLE ON DISCHARGE ON (B)(6) 2024
Patient problems: Back pain; Chest Pain; Pneumonia; Pulmonary Embolism; Tachycardia
MAUDE report 21578331 ↗MalfunctionJan 14, 2025Migration; Migration
THE EVENT WAS IDENTIFIED DURING A REVIEW OF THE PMCF LUMBAR INTERBODY STUDY, THE REPORT IDENTIFIED THAT ON (B)(6) 2022 A PATIENT UNDERWENT A TWO LEVEL TRANSFORAMINAL LUMBAR INTERBODY FUSION PROCEDURE AT L4/5 AND L5/S1. ON (B)(6) 2022 FOLLOW UP RADIOGRAPHS NOTED SUBSIDENCE OF BOTH INTERBODY'S (L4-5, L5-S1). NO REVISION OR TREATMENT PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21149470 ↗
Other Intervertebral fusion device with bone graft, lumbar devices
- T-PAL 03.812.003Synthes GmbH · Intervertebral fusion device with bone graft, lumbar152 reports
- T-PAL 03.812.004Synthes GmbH · Intervertebral fusion device with bone graft, lumbar120 reports
- Catalyft PL Expandable Interbody System 6068073Medtronic Sofamor Danek, Inc. · Intervertebral fusion device with bone graft, lumbar1 recall66 reports
- Catalyft PL Expandable Interbody System 6069076Medtronic Sofamor Danek, Inc. · Intervertebral fusion device with bone graft, lumbar1 recall51 reports
- Catalyft PL Expandable Interbody System 6068076Medtronic Sofamor Danek, Inc. · Intervertebral fusion device with bone graft, lumbar1 recall46 reports
- EIT TLIF Inserter TFT30101EIT Emerging Implant Technologies GmbH · Intervertebral Fusion Device With Bone Graft, Lumbar88 reports
- T-PAL 03.812.001Synthes GmbH · Intervertebral fusion device with bone graft, lumbar76 reports
- Catalyft PL Expandable Interbody System 6069096Medtronic Sofamor Danek, Inc. · Intervertebral fusion device with bone graft, lumbar1 recall25 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page